E

Emalex Biosciences

19 employees

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Innovation
Health Care
Therapeutics
Central Nervous System (CNS) disorders
Pharmaceutical
Biopharma
Research and development
Biopharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$250M

from 3 investors over 3 rounds

E

Emalex Biosciences raised $250M on November 3, 2022

Investors: Paragon Biosciences and Valor Equity Partners

E

Emalex Biosciences raised $15M on June 3, 2020

Investors: Horizon Technology Finance

FAQ